Allworth Financial’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Allworth Financial’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$11K	–	1478
2020 Q3	$11K	Hold	200	–	–	﹤0.01%	703
2020 Q2	$12K	Hold	200	–	–	﹤0.01%	693
2020 Q1	$11K	Hold	200	–	–	﹤0.01%	688
2019 Q4	$11K	Hold	200	–	–	﹤0.01%	640
2019 Q3	$11K	Hold	200	–	–	﹤0.01%	573
2019 Q2	$12K	Hold	200	–	–	﹤0.01%	558
2019 Q1	$12K	Hold	200	–	–	﹤0.01%	554
2018 Q4	$12K	Hold	200	–	–	﹤0.01%	496
2018 Q3	$12K	Hold	200	–	–	﹤0.01%	534
2018 Q2	$9K	Hold	200	–	–	﹤0.01%	551
2018 Q1	$9K	Hold	200	–	–	﹤0.01%	517
2017 Q4	$9K	Hold	200	–	–	﹤0.01%	500
2017 Q3	$9K	Buy	+200	New	+$9.58K	﹤0.01%	491

Other funds holding BSTC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Allworth Financial's BSTC Position: Q4 2020 in Review

Allworth Financial sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 200 shares — an estimated $11K sold.

Allworth Financial first reported a position in BSTC in Q3 2017 and held it in 13 quarters. The position peaked at $12K in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

Allworth Financial reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
Allworth Financial sold 200 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $11K.
Allworth Financial first reported a position in BioSpecifics Technologies Corp. in Q3 2017 and held it in 13 quarters.
Allworth Financial's BioSpecifics Technologies Corp. position peaked at $12K in Q2 2020.
1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Allworth Financial's 13F filing for Q4 2020, filed 26 Jan 2021.